©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 113976
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113976
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113976
Table 4 Comparison of features between the training and validation sets, n (%)
| Variables | Total (n = 300) | Validation (n = 90) | Training (n = 210) | Statistic | P value |
| Gender | χ² = 0.22 | 0.639 | |||
| Female | 89 (29.67) | 25 (27.78) | 64 (30.48) | ||
| Male | 211 (70.33) | 65 (72.22) | 146 (69.52) | ||
| Age | χ² = 0.77 | 0.381 | |||
| < 50 | 118 (39.33) | 32 (35.56) | 86 (40.95) | ||
| ≥ 50 | 182 (60.67) | 58 (64.44) | 124 (59.05) | ||
| BMI | χ² = 0.26 | 0.614 | |||
| < 25 | 216 (72.00) | 63 (70.00) | 153 (72.86) | ||
| ≥ 25 | 84 (28.00) | 27 (30.00) | 57 (27.14) | ||
| Adjuvant therapy | χ² = 1.13 | 0.288 | |||
| No | 72 (24.00) | 18 (20.00) | 54 (25.71) | ||
| Yes | 228 (76.00) | 72 (80.00) | 156 (74.29) | ||
| T stage | χ² = 1.52 | 0.678 | |||
| T1 | 50 (16.67) | 14 (15.56) | 36 (17.14) | ||
| T2 | 49 (16.33) | 16 (17.78) | 33 (15.71) | ||
| T3 | 129 (43.00) | 42 (46.67) | 87 (41.43) | ||
| T4 | 72 (24.00) | 18 (20.00) | 54 (25.71) | ||
| N stage | χ² = 2.46 | 0.483 | |||
| N0 | 100 (33.33) | 28 (31.11) | 72 (34.29) | ||
| N1 | 54 (18.00) | 19 (21.11) | 35 (16.67) | ||
| N2 | 50 (16.67) | 18 (20.00) | 32 (15.24) | ||
| N3 | 96 (32.00) | 25 (27.78) | 71 (33.81) | ||
| LN meta | χ² = 0.85 | 0.355 | |||
| No | 105 (35.00) | 28 (31.11) | 77 (36.67) | ||
| Yes | 195 (65.00) | 62 (68.89) | 133 (63.33) | ||
| Vein inv | χ² = 0.21 | 0.646 | |||
| No | 126 (42.00) | 36 (40.00) | 90 (42.86) | ||
| Yes | 174 (58.00) | 54 (60.00) | 120 (57.14) | ||
| Nerve inv | χ² = 1.03 | 0.309 | |||
| No | 130 (43.33) | 43 (47.78) | 87 (41.43) | ||
| Yes | 170 (56.67) | 47 (52.22) | 123 (58.57) | ||
| CTI | χ² = 0.11 | 0.741 | |||
| < 9.07 | 169 (56.33) | 52 (57.78) | 117 (55.71) | ||
| ≥ 9.07 | 131 (43.67) | 38 (42.22) | 93 (44.29) | ||
| PNI | χ² = 0.25 | 0.616 | |||
| < 45 | 86 (28.67) | 24 (26.67) | 62 (29.52) | ||
| ≥ 45 | 214 (71.33) | 66 (73.33) | 148 (70.48) | ||
| CEA | χ² = 0.58 | 0.446 | |||
| < 3 | 170 (56.67) | 54 (60.00) | 116 (55.24) | ||
| ≥ 3 | 130 (43.33) | 36 (40.00) | 94 (44.76) | ||
| CA199 | χ² = 2.24 | 0.135 | |||
| < 37 | 256 (85.33) | 81 (90.00) | 175 (83.33) | ||
| ≥ 37 | 44 (14.67) | 9 (10.00) | 35 (16.67) |
- Citation: Hao QL, Yao ZY, Shen YM, Li ZY, Gao HC, Hong XY, Li GC, Gao C. Prognostic significance of preoperative C-reactive protein-triglyceride-glucose index in long-term outcomes after radical gastrectomy for gastric cancer. World J Gastrointest Oncol 2025; 17(12): 113976
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/113976.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.113976